Search

You searched for "choroideal"

313 results found

My ophthalmic elective: focusing on myopia in Taiwan

3 June 2021 | | EYE - Cataract, EYE - Refractive, EYE - General
The authors describe their elective experience and delve further into high myopia, an emerging ophthalmic disease that is increasingly recognised in and outside Asia. The medical school elective programme presents an opportunity for students to conduct learning in their chosen...

Comparison of retinal pigment epithelium-choroid graft surgery and anti-VEGF therapy in patients with wet AMD

1 December 2015 | | EYE - Vitreo-Retinal
This was a randomised intervention study in wet AMD patients to investigate benefits of free RPE-choroid graft transplantation surgery versus (continuation of) anti-VEGF treatment. Twenty patients who met the inclusion criteria were subdivided into three subgroups, i.e. RPE tears involving...

Ozurdex use in noninfectious uveitis

1 June 2016 | | EYE - Vitreo-Retinal
Burkholder et al. reported the practice patterns of 45 respondents of approximately 176 surveyed members of the American Uveitis Society regarding the use of the Ozurdex implant. Most respondents performed the injection in either a procedure (41.0%) or clinic (23.1%)...

What's trending Aug/Sep 2022

2 August 2022 | | EYE - General
A round-up of the eye related hot topics that have been trending on social media over the last few weeks. #JustinBieber #RamsayHuntsyndrome #facialparalysis Justin Bieber revealed he has been afflicted by Ramsay Hunt syndrome, and thus has had to cancel...

Can OCT predict Alzheimer’s disease?

5 February 2020 | | EYE - Imaging, EYE - General
Simerdip Kaur takes a look at the latest ophthalmology-related news stories and asks which are based on facts and which are ‘fake news’. Headline: Can OCT predict Alzheimer’s disease? In 1986 Hinton et al. demonstrated evidence of optic nerve degeneration...

Macula re-attachment following intravitreal ranibizumab in rhegmatogenous retinal detachment

1 February 2015 | | EYE - Vitreo-Retinal, EYE - General
Ranibizumab (Lucentis) is a vascular endothelial growth factor inhibitor (anti-VEGF) used for treatment of choroidal neovascular membrane [1]. We report a case where macula off inferior rhegmatogenous retinal detachment was misdiagnosed as wet age-related macular degeneration (AMD) and three intravitreal...

On becoming a man

1 October 2018 | | EYE - Vitreo-Retinal, EYE - General
It was at the height of the gender debate, with Donald Trump banning transsexuals from serving in the US army and parts of the first world indulging in controversies on whether separate transgender toilets are needed, that a 40-year-old lady,...

A tale of two membranes

1 February 2016 | | EYE - Vitreo-Retinal
It was the best of times, it was the worst of times... It was the season of Light, it was the season of Darkness... I am fortunate to work on a vitreoretinal firm at the moment and only a few...

My top five Instagram accounts to keep your scrolling educational

4 August 2021 | | EYE - Vitreo-Retinal, EYE - General
There’s no denying that now, more than ever, we are better connected to our electronic devices; 24/7, around the clock. The phenomenon of ‘Zoom’ and ‘Microsoft Teams’ is shaping the future of medical education, national trainee recruitment and conference access....

My Top Five: Instagram accounts to keep your scrolling educational

4 August 2021 | | EYE - General, EYE - Vitreo-Retinal
There’s no denying that now, more than ever, we are better connected to our electronic devices; 24/7, around the clock. The phenomenon of ‘Zoom’ and ‘Microsoft Teams’ is shaping the future of medical education, national trainee recruitment and conference access....

My Top Five: Innovations in the diagnosis of ocular tumours

4 February 2025 | | EYE - Oncology, EYE - Orbit, EYE - Pathology
Ocular tumours can vary widely in origin, from benign growths to metastases from distant disseminated malignancies. Although rare, ocular tumours pose a significant health and economic burden globally, with ocular cancers accounting for 0.2% of all diagnosed malignancies in the...

Neovascular AMD: fresh recommendations underline standards of best practice

1 December 2013 |
The management of neovascular age-related macular degeneration (nAMD) has advanced dramatically over the past seven years, with the introduction of targeted new therapies that successfully maintain or improve vision in a majority of affected individuals. It’s a fast moving field,...